SCHEMBL5017729

SCHEMBL5017729

SCc1cc(Cl)ccn1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7418086 0.83 PDE8A (0.43)
SCHEMBL509733 0.79
SCHEMBL29774155 0.79
SCHEMBL1507045 0.77
SCHEMBL5955760 0.77
SCHEMBL510676 0.77
SCHEMBL379949 0.77
Hydrochloric Acid SCHEMBL31198157 0.77 PDE8A (0.39)
SCHEMBL17103357 0.77
Hydrochloric Acid SCHEMBL1157373 0.77 PDE8A (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7314940-B2 For therapy and prophylaxis of neurodegenerative disorders related to apoptosis and/or inflammation EISAI CO., LTD. (JP) 2008-01-01 US disclosed
EP-1373269-B1 JUN KINASE INHIBITORS EISAI CO LTD (JP) 2005-06-08 EP disclosed
US-20040235864-A1 Jun kinase inhibitors EISAI R & D MANAGEMENT CO., LTD. (JP) 2004-11-25 US disclosed
EP-1373269-A1 JUN KINASE INHIBITORS Eisai Co., Ltd. (JP) 2004-01-02 EP disclosed
WO-2002081475-A1 JUN KINASE INHIBITORS EISAI CO., LIMITED (JP) 2002-10-17 WO disclosed